Evommune EVMN Stock Issued During Period, Value, Conversion of Convertible Securities
Stock Issued During Period, Value, Conversion of Convertible Securities at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities.
The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's stock issued during period, value, conversion of convertible securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's stock issued during period, value, conversion of convertible securities?
- Evommune (EVMN) reported stock issued during period, value, conversion of convertible securities of $122.33K in Q1 2025.
- What does stock issued during period, value, conversion of convertible securities mean?
- Represents the total dollar value of equity issued resulting from the conversion of convertible debt or preferred securities into common stock. This metric highlights the impact of capital structure changes on shareholder dilution and the reduction of debt or preferred obligations. It is a key indicator of how a company manages its long-term financing obligations through equity conversion.